Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-122341

VP, Finance and Controller sold 390 shares at $8.61 ($3,358)

  • VP, Finance and Controller acquired 1,086 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gupta Ashoo · VP, Finance and Controller

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-20 Exercise or conversion : show line 1 in the form +865 47,224 D
2026-03-20 Sale : show line 2 in the form −310 $8.61 $2,669 46,914 D
2026-03-20 Exercise or conversion : show line 3 in the form +221 47,135 D
2026-03-20 Sale : show line 4 in the form −80 $8.61 $689 47,055 D
Open-market sales · 390 sh · avg $8.61 · $3,358

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-20 Exercise or conversion : show line 5 in the form Restricted Stock Units −865 12,119 D
2026-03-20 Exercise or conversion : show line 6 in the form Restricted Stock Units −221 3,087 D
Loading xslF345X06/ownership.xml…